Cancer clinical trials in the region Pays de la Loire
199 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT05853575
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Targeted therapy
7 main criterias to confirm
Centre Hospitalier Universitaire de Nantes (Nantes), Centre Hospitalier Universitaire Angers (Angers )
Mirati Thérapeutique Inc.
Phase 2
Prostate cancer
#NCT05826509
Adenocarcinoma
Localized
Systemic Treatment-Naive
Systemic Treatment-Naive
None
6 main criterias to confirm
CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Régional Universitaire de Tours (Tours)
Institut Claudius Regaud
Phase 2
Liver and bile duct cancer
#NCT05797870
Hepatocellular carcinoma
Localized
None
1
2
Unhealthy
A
B
C
6 main criterias to confirm
Centre Eugene Marquis (Rennes)
Centre Eugène Marquis
Phase 2
Colon cancer
Rectal cancer
#NCT05706129
Locally Advanced
Metastatic
Chemotherapy
Targeted therapy
1
2
3 or more
4 main criterias to confirm
Centre Hospitalier Universitaire de Nantes (Nantes)
Debiopharm International SA
Phase 2
Pancreas cancer
#NCT05706129
Adenocarcinoma
Locally Advanced
Metastatic
Chemotherapy
1
2
3 or more
5 main criterias to confirm
Centre Hospitalier Universitaire de Nantes (Nantes)
Debiopharm International SA
Phase 2
Kidney cancer
#NCT05706129
Clear cell carcinoma
Locally Advanced
Metastatic
Targeted therapy
Immunotherapy
Targeted therapy
2
3 or more
6 main criterias to confirm
Centre Hospitalier Universitaire de Nantes (Nantes)
Debiopharm International SA
Phase 2
Lung cancer
#NCT05673187
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
KRAS G12C
Immunotherapy
Chemotherapy
1
2
3 or more
Systemic Treatment-Naive
Targeted therapy
7 main criterias to confirm
Centre Hospitalier du Mans (Le Mans)
Thérapeutique Mirati Inc
Phase 2
Breast cancer
#NCT05625087
HER2 Negative
HR Positive
Metastatic
PIK3CA
Hormone therapy
Systemic Treatment-Naive
1
8 main criterias to confirm
Centre Hospitalier de Cholet (Cholet), Centre Eugene Marquis (Rennes), Institut de Cancérologie Radiothérapie Brétillien / CHP Saint Grégoire - Vivalto Santé (Saint-Grégoire), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon), Centre Hospitalier de Blois (Blois)
UNICANCER
Phase 2
Lung cancer
#NCT05617963
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
Systemic Treatment-Naive
Systemic Treatment-Naive
None
6 main criterias to confirm
Centre Hospitalier de Cholet (Cholet), Hôpital Privé du Confluent - Vivalto Santé (Nantes), Centre Hospitalier Universitaire Angers (Angers )
UNICANCER
Phase 2
Lung cancer
#NCT05609578
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
Immunotherapy
Chemotherapy
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
None
Targeted therapy
Targeted therapy
10 main criterias to confirm
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers )
Mirati Thérapeutique Inc.